CARM1 and triple-negative breast carcinoma: Moreover, the parallels to CARM1 biology strengthen the mechanistic plausibility: in triple-negative breast cancer, CARM1 promotes proliferation, epithelial–mesenchymal transition (EMT), and stemness, in part by interacting with β-catenin and influencing Wnt pathway targets [84].